NeoGenomics, Inc. NEO
$16.25
-0.64%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $19.71
- Implied Upside
- +21.4%
- Price Target Range
- $13.00 – $28.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-06 | StoneXBruce D. Jackson |
Maintains | Buy | $16 → $20 |
| 2026-10-06 | NeedhamMike Matson |
Maintains | Buy | $19 → $22 |
| 2026-10-06 | BTIGMark Massaro |
Upgrades | Neutral → Buy | $28 |
| 2026-07-29 | NeedhamMike Matson |
Maintains | Buy | $15 → $19 |
| 2026-07-24 | BenchmarkBruce D. Jackson |
Maintains | Buy | $11 → $16 |
| 2026-04-29 | BenchmarkBruce Jackson |
Upgrades | Hold → Buy | $11 |
| 2026-04-29 | TD CowenDan Brennan |
Maintains | Buy | $13 → $14 |
| 2026-04-29 | Leerink PartnersPuneet Souda |
Upgrades | Market perform → Outperform | $12 → $25 |
| 2026-02-24 | Piper SandlerDavid Westenberg |
Maintains | Overweight | $12 → $13 |
| 2026-02-17 | NeedhamMike Matson |
Maintains | Buy | $14 → $15 |
| 2026-01-12 | NeedhamMike Matson |
Reiterates | Buy | $14 |
| 2025-09-12 | TD CowenDan Brennan |
Maintains | Buy | $10 → $12 |
| 2025-09-02 | Stephens & Co.Mason Carrico |
Maintains | Overweight | $7 → $11 |
| 2025-08-29 | NeedhamMike Matson |
Maintains | Buy | $8 → $14 |
| 2025-08-04 | Piper SandlerDavid Westenberg |
Maintains | Overweight | $12 → $11 |
| 2025-07-30 | Morgan StanleyTejas Savant |
Maintains | Equal-weight | $10 → $8 |
| 2025-07-29 | NeedhamMike Matson |
Maintains | Buy | $9 → $8 |
| 2025-07-29 | William Blair |
Downgrades | Outperform → Market perform | — |
| 2025-05-06 | Piper SandlerDavid Westenberg |
Maintains | Overweight | $18 → $12 |
| 2025-05-01 | Morgan StanleyTejas Savant |
Maintains | Equal-weight | $17 → $10 |
| 2025-04-30 | Goldman SachsMatthew Sykes |
Maintains | Buy | $15 → $10 |
| 2025-04-30 | Leerink PartnersPuneet Souda |
Downgrades | Outperform → Market perform | $25 → $9 |
| 2025-04-29 | NeedhamMike Matson |
Maintains | Buy | $18 → $9 |
| 2025-04-17 | Goldman SachsMatthew Sykes |
Maintains | Buy | $17 → $15 |
| 2025-02-26 | Piper SandlerDavid Westenberg |
Maintains | Overweight | $21 → $18 |
| 2025-02-19 | B of A SecuritiesDerik De Bruin |
Maintains | Neutral | $19 → $16 |
| 2025-02-19 | NeedhamMike Matson |
Maintains | Buy | $19 → $18 |
| 2025-01-28 | Goldman SachsMatthew Sykes |
Maintains | Buy | $20 → $18 |
| 2025-01-16 | BenchmarkBruce Jackson |
Reiterates | Hold | — |
| 2025-01-15 | NeedhamMike Matson |
Reiterates | Buy | $19 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $16.25
- Market Cap
- $2.10 billion
- 52-Week Range
- $7.07 – $20.15
- Average Volume
- 2.16 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.